ADAM17 anticorps (C-Term)
Aperçu rapide pour ADAM17 anticorps (C-Term) (ABIN1030720)
Antigène
Voir toutes ADAM17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- 80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
-
Purification
- Affinity chromatography purified via peptide column
-
-
-
-
Indications d'application
- TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
-
: "ADAM-17: a novel therapeutic target for triple negative breast cancer." dans: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, (2013) (PubMed).
-
-
- ADAM17 (ADAM Metallopeptidase Domain 17 (ADAM17))
-
Autre désignation
- TACE
-
Poids moléculaire
- Predicted: 93 kDa
-
Pathways
- Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Antigène
-